Skip to main content
ASPHO Logo
Menu Journal My Account Contact Join/Renew
Login
  • Meetings & Events
    • Conference
      • 2025 Conference
      • Continuing Education
      • Press | 2018 Conference
      • 2018 Call for Papers and Posters
        • Back to Meetings
        • 2019 Conference
        • Schedule of Events
        • Registration Rates
        • Conference Planning Committee
        • Conference Hotel and Travel
        • Faculty
        • 2019 Call for Papers and Posters
        • Continuing Education
        • PBMTC
        • Accepted Papers and Posters
        • Corporate Symposia
        • MOC Opportunities
        • App - Thank you for Attending
        • 2019 Attendee List
      • 2018 Conference
        • Schedule of Events
        • Accepted Papers and Posters
      • 2016 Annual Meeting
        • Overview
        • Attendee List
        • ASPHO Virtual Bag
        • Corporate Forum Symposia/Education Theaters
        • Accepted Papers and Posters
          • Accepted A-G
          • Accepted H-M
          • Accepted N-Z
          • 2016 Searchable Abstract Database
        • Exhibit Hall
        • Sponsors
        • Annual Meeting Brochure
        • Virtual Bag
        • Schedule of Events
        • Continuing Education
        • Attendee List
        • 2017 Searchable Abstract Database
        • Accepted Papers and Posters
        • Corporate Forum Symposia/Education Theater
        • Travel
        • Program Committee
        • Commercial Support
        • Exhibit with ASPHO
      • Hotel and Travel Information
      • Registration
      • Schedule
      • Corporate Symposia
      • Commercial Support
      • Meetings Archive
      • Registration Information
      • 2026 Conference
    • Review Course
      • Anderson 2019
      • McClain 2019
      • Adams 2019
      • Moran 2019
      • Effinger 2019
      • Fangusaro 2021
      • Brown 2021
      • Young 2021
      • Harker-Murray 2021
      • Effinger 2021
      • Pai 2021
      • Grace 2021
      • Rogers 2021
      • Anderson 2021
      • Powers 2021
      • McClain 2021
      • Neunert 2021
      • Fleming 2021
      • Mullen 2021
      • Pommert 2021
      • Meade 2021
      • Greengard 2021
      • Fox 2021
      • Bercovitz 2021
      • Brock 2021
      • Adams 2021
      • Loh 2021
      • O'Brien 2021
      • Walterhouse 2021
      • Pulsipher 2021
      • Oberley 2021
      • Rodriguez-Galindo 2021
      • Kesselheim 2021
      • Frei-Jones 2021
      • Allen 2021
      • 2015 Online Review Course CME Certificates
      • 2019 Planning Committee
      • 2019 Schedule
      • 2019 Travel
      • 2019 Review Course Early Career
      • 2019 Review Course Directors
        • 2019 Review Course Faculty
      • Oberley 2019
      • O'Brien 2019
      • Pai 2019
      • Pulsipher 2019
      • Rodriguez-Galindo 2019
      • Rogers 2019
      • Walterhouse 2019
      • Young 2019
      • Park 2019
      • Malec 2019
      • Evaluations
      • Brown 2019
      • Allen 2019
      • Fangusaro 2019
      • Fleming 2019
      • Frei-Jones 2019
      • Grace 2019
      • Harker-Murray 2019
      • Heeney 2019
      • Kesselheim 2019
      • Loh 2019
      • Mascarenhas 2019
      • Neunert 2019
      • Fangusaro 2023
      • Adams 2023
      • Neunert 2023
      • Oberley 2023
      • Grace 2023
      • Effinger 2023
      • Nakano 2023
      • Brock 2023
      • Harker-Murray 2023
      • Meade 2023
      • Fleming 2023
      • Kesselheim
      • Kumar 2023
      • Anderson 2023
      • Malogolowkin 2023
      • Pommert 2023
      • Bercovitz 2023
      • Frei-Jones 2023
      • O'Brien 2023
      • Pai 2023
      • Young 2023
      • Fox 2023
      • Powers 2023
      • Pulsipher 2023
      • McClain 2023
      • Loh 2023
      • Greengard 2023
      • Frazier 2023
      • Brennan 2023
      • Walkovich 2023
      • Browning 2023
      • Mullen 2023
      • 2025 Review Course
        • 2025 Faculty
        • 2025 Learning Objectives and CME
        • 2025 Schedule
        • 2025 Cancellation Policies and Disclosures
        • 2025 Planning Committee
        • Young 2025
        • Bercovitz 2025
        • Brennan 2025
        • Fangusaro 2025
        • Fox 2025
        • Frazier 2025
        • Greengard 2025
        • O'Brien 2025
        • Pommert 2025
        • Powers 2025
        • Pulsipher 2025
        • Walkovich 2025
        • Neunert 2025
        • Adams 2025
        • Oberley 2025
        • Grace 2025
        • Effinger 2025
        • Nakano 2025
        • Brock 2025
        • Harker-Murray 2025
        • Meade 2025
        • Fleming 2025
        • Kesselheim 2025
        • Kumar 2025
        • Creary 2025
        • DeNardo 2025
        • Dome 2025
        • Jordan 2025
        • McCavit 2025
        • Pai 2025
        • Raetz 2025
        • Malogolowkin 2025
        • Terrell 2025
        • Kucine 2025
      • Learning Objectives and CME
      • Faculty
      • Schedule
      • Policies
    • Events Calendar
  • Knowledge Center
    • Products
      • KARE Toolkit: Knowledge and Assessment Resources
        • CME for KARE
        • CME for RC On-Demand
        • CME for PHO Review Course On Demand
        • CME for KARE Plus
        • CME for KARE Plus Hematology
        • CME for KARE Plus Oncology
        • The KARE Toolkit - Index of Topics
      • Webinars
      • ASPHOcast
      • Alexion Recording
      • 2024 Compensation Survey
      • Webinar Toolkit
      • Compensation and Benefits Report
      • View the Compensation and Benefits Survey Report
      • Compensation Tool
    • Online Review Course
    • Pediatric Blood & Cancer
      • Access Journal
      • Online Access Instructions
    • ASPHO eNews
      • August 2015 Enews
      • June 2015 Enews
      • April 2015 Enews
      • February 2015 Enews
      • December 2014 Enews
      • October 2014 Enews
      • August 2014 Enews
      • June 2014 Enews
      • April 2014 Enews
      • February 2014 Enews
      • December 2013 Enews
      • October 2013 Enews
      • August 2013 Enews
      • June 2013 Enews
      • April 2013 Enews
      • February 2013 Enews
      • October 2014 Enews
      • October 2015 Enews
      • December 2015 Enews
      • February 2016 Enews
      • April 2016 Enews
      • June 2016 Enews
        • DSIG Student Registration
      • August 2016 Enews
      • October 2016 Enews
      • December 2016 Enews
      • February 2017 Enews
      • April 2017 Enews
      • June 2017 Enews
      • August 2017 Enews
      • October 2017 Enews
      • December 2017 Enews
      • February 2018 Enews
      • April 2018 Enews
      • June 2018 Enews
      • August 2018 eNews
      • October 2018 eNews
      • February 2019 eNews
      • Member Insights: eNews 2018 Highlights
      • April 2019 eNews
      • June 2019 eNews
      • August 2019 eNews
      • October 2019 eNews
      • December 2019 eNews
      • February 2020 eNews
      • April 2020 eNews
      • June 2020 eNews
      • August 2020 eNews
      • October 2020 eNews
      • December 2020 eNews
      • April 2021 eNews
      • June 2021 eNews
      • August 2021 eNews
        • August 2021 President's Message
      • December 2021 eNews
      • February 2022 eNews
      • April 2022 eNews
      • June 2022 eNews
      • August 2022 eNews
      • October 2022 eNews
      • December 2022 eNews
      • February 2023 eNews
      • April 2023 eNews
      • June 2023 eNews
      • October 2023 eNews
      • December 2023 eNews
      • February 2024 eNews
      • March 2024 eNews
      • April 2024 eNews
      • June 2024 eNews
      • August 2024 eNews
      • October 2024 eNews
      • December 2024 eNews
      • February 2025 eNews
      • April 2025 eNews
    • Pediatric Blood & Cancer - Call for Applications for Deputy Editor
    • October 2015 Enews
    • Advocacy Sample
    • News Briefs
    • Health Policy & Advocacy
      • 2016 August Advocacy Brief
      • 2016 December Advocacy Brief
      • 2017 February Advocacy Brief
      • 2017 May Advocacy Brief
      • 2017 September Advocacy Brief
      • 2017 November Advocacy Brief
      • 2018 Advocacy Brief - March
      • Contact Your Members of Congress
      • 2018-Advocacy-Brief-June
      • 2018-Advocacy-Brief-September
      • Advocacy Brief December 2018
      • 2019 Advocacy Brief - March
      • March 2019 Advocacy Brief
      • June 2019 Advocacy Brief
      • September 2019 Advocacy Brief
      • March 2020 Advocacy Brief
      • June 2020 Advocacy Brief
      • September 2020 Advocacy Brief
      • December 2020 Advocacy Brief
      • June 2021 Advocacy Brief
      • September 2021 Advocacy Brief
      • March 2022 Advocacy Brief
      • June 2022 Advocacy Brief
      • September 2022 Advocacy Brief
      • March 2024 Advocacy Brief
      • September 2024 Advocacy Brief
      • December 2024 Advocacy Brief
      • March 2025 Advocacy Brief
    • 2017 Workforce Survey Report
    • Help Fund the STAT Act
    • Practice and Quality
      • Choosing Wisely®
      • Position Paper
      • Endorsements
      • ASPHO Endorsements member only
  • Career Development
    • Mentoring
      • Early Career Mentoring
    • Awards
      • Distinguished Career Award
      • Oski Memorial Lectureship
      • International Travel Awards
      • Buchanan Lectureship
      • Young Investigator Award
      • Young Investigator Form
      • EC Travel Stipend Form
      • Early Career Travel Stipend
      • Advanced Practice Provider Award
      • Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
    • Career Center
    • Fellowship Resources
      • Post-PHO Fellowship Program Directory
      • Fellowship Program Directors' Resources
    • Certification
      • Continuing Medical Education
      • advocating for moc
      • ABP MOC Letter Nov 2015
      • ABP Hematology/Oncology Content Outline
    • 2019 ASPHO Award Recipients
    • Workforce
  • Membership
    • Who Belongs
    • Benefits
    • Join Us
    • Renew
    • Membership Application
    • Fellows Group Application
    • Member Community
    • Find a Member
    • Special Interest Groups
      • Adolescent and Young Adult SIG
      • Advanced Practice Provider SIG
      • Cancer Predisposition SIG
      • Clinical Immunology SIG
      • Diversity SIG
        • 2017 DSIG Travel Award
      • Global Hem Onc SIG
      • Hemoglobinopathy SIG
      • Hospitalist Medicine SIG
      • Informatics, Innovation and Entrepreneurship SIG
      • Integrative Pediatric Hematology/Oncology SIG
      • Palliative Care SIG
      • Physician Scientist SIG
      • Quality Improvement and Patient Safety SIG
      • Small Program SIG
      • Vascular Anomalies SIG
      • Clinical Immunology SIG Webinar
      • Well-Being SIG
    • Enriching the Future
      • ETF Donors
      • ETF FAQ
      • ETF Programs
      • ETF Award Recipients
      • Donate
    • Stay Connected with ASPHO
    • New Member
    • Trainee Membership Level
    • Strengthen Your Everyday Practice
  • About
    • Governance
      • 2017 Election Nominations
      • 2019 Board and Nominating Committee members
      • Board of Trustees
      • Leadership Development & Election Process
      • Nominating FAQs
      • Strategic Plan
        • Leadership Domain
        • Education Domain
        • Career Domain
        • Administration Domain
      • Volunteer Opportunities
        • Early Career Council
    • Policies
      • Advertising Sponsorship
      • Support of CME
      • Committee Policies, Responsibilities, and Resources
      • Conflict of Interest and Disclosure for Volunteers
      • Distinguished Career Award Eligibility Criteria
      • Diversity Statement
      • Investment
      • Member Mailing List
      • Oski Eligibility Criteria
      • Presidential Stipend
      • Records Retention
      • Reserve Fund
      • Reviews and Endorsements
      • Speaker Reimbursement
      • Surveying Members
      • Whistleblower
      • Workshop Session
      • Young Investigator Award
      • Early Career Travel Stipend
      • Buchanan Lectureship Eligibility
      • ASPHO Statements
    • Terms of Use
    • Contact Us
    • 2016 Election Nominations
    • 2015 Election Candidates
    • FDA Approves Dinutuximab
    • Q&A Amy Billett
    • Fund Raising Policy
    • Support and Advertising
      • Exhibit
      • Advertising
      • Industry Relations Council
      • Grants
    • Diversity & Inclusion
    • Donate
    • DEI Member Perspectives
    • Account Access
  • 2017 Annual Meeting Session Recordings
  • 2018 Annual Meeting Session Recordings
  • George R. Buchanan Lectureship Award Presentation
  • Cancer Predispositions in Clinical Practice
  • Evidence and Equipoise in Pediatric Thrombosis - Updates from Randomized Controlled Trials
  • Playing on Our Strengths - Developing Interprofessional Teams in Pediatric Hematology-Oncology
  • Providing Optimal Pediatric Palliative Care: Overcoming the Barriers
  • When in Quebec, Do What the Quebecers Do (Part Deux) - It's All About Platelets!
  • Allogeneic Hematopoietic Stem Cell Transplantation (SCT) for Pediatric Patients with ALL in the era of Tyrosine Kinase Inhibitors, Novel Immunotherapies and 'MRD Status'
  • Award Presentations
  • Hemophilic Arthropathy, More Than Meets the Eye: Advances in Early Disease Detection from Clinical Tools to Musculoskeletal Imaging
  • ZFNs, CrispR/Cas9 and TALENS- Oh My!
  • Collaboration in the Treatment of Liver Tumors
  • Leukemia
  • Solid Tumors/Lymphoma
  • Hematology I
  • Beyond Antibodies and CAR T Cells: Challenges and Opportunities in Manipulating the Pediatric Cancer Immunome
  • Blood Clots in Sick Kids: A critical mini-review of venous thrombo-embolism in selected high-risk pediatric populations
  • It's not just about Diversity: Improving the Outcomes for All by Moving toward Equity
  • Children's Oncology Group (COG)
  • Outcomes Research
  • Social Media: The Good, The Bad, and Beyond
  • Sickle Cell Disease in the AYA population: Management Challenges for the Pediatric Hematologist
  • Molecularly Defined Rare Pediatric Sarcomas: An Update for the General Oncologist
  • Mechanisms of Tumor Microenvironment Immune Mediated Resistance and Methods of Therapeutic Circumvention
  • Behind the Scenes at Pediatric Blood & Cancer: Everything You Always Wanted to Know About Getting Published
  • New Insights in Inherited Hematologic Diseases
  • Changing Workforce of Pediatric Hematology/Oncology
  • New Diagnostic and Therapeutic Approaches of Opportunistic (Viral/Fungal) Infections in the Pediatric Cancer Patient
  • New Mutations and Targeted Therapies in Langerhans Cell Histiocytosis
  • Physician, Sustain Thyself: Building Resilience to Prevent Burnout
  • Practicing Precision in Pediatric Oncology: Three Perspectives
  • What's Happening in DC? A Look at ASPHO Advocacy Efforts
  • Critical Care of the Immunocompromised Pediatric Hematology/Oncology Patient
  • Brain Tumors
  • Hematology II
  • Sponsor, Exhibit, and Advertise
    • Exhibits
    • Advertising
    • Industry Relations Council
    • Exhibits Adveritising
  • Ward Testing OSE
  • 2018 Session | George R. Buchanan Lectureship Award Presentation
  • 2018 Session | Plenary Paper Session 2001-2002
  • 2018 Session | St. Baldrick's Foundation Robert J. Arceci Innovation Award Announcement
  • 2018 Session | Plenary Session—Health Care in the Current Political Climate: Stormy Days Ahead?
  • 2018 Session | Pediatric Ependymoma: The Science Driving Patient Care
  • 2018 Session | Iron: Let's Get Pumped
  • 2018 Session | Extracellular Vesicle Trafficking—Biology and Translational Impact in Hematology and Cancer
  • 2018 Session | Relapsed, Refractory, Metastatic Bone Sarcomas: New Insights on Pathogenesis, Prognosis and Treatment
  • 2018 Session | Alpha Thalassemia—A Growing Public Health Disease with Changing Landscape of In-Utero and Post-Natal Therapy
  • 2018 Session | Decision Making in Benign Hematology: Living in a World Without Randomized Trials
  • 2018 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
  • 2018 Session | Early Career Travel Stipend Awards
  • 2018 Session | Young Investigator Award Presentations
  • 2018 Session | Management of Extracranial Germ Cell Tumors in Adolescent and Young Adult Population
  • 2018 Session | Challenging Hematologic Complications Post–Stem Cell Transplantation and Beyond
  • 2018 Session | Advanced Symptom Management and End-of-Life Care: Multidisciplinary Primary Palliative Care for Pediatric Hematologists/Oncologists
  • 2018 Session | Paper Session - Solid Tumor
  • 2018 Session | Paper Session - Hematology
  • 2018 Session | Vascular Anomalies: The Great Mimickers
  • 2018 Session | Addressing Sexual Health in Adolescent and Young Adult Patients: What You Should Know as a Pediatric Hematology/Oncology Care Provider
  • 2018 Session | Navigating Intravascular Bottlenecks: A Critical Mini-Review of Pediatric Venous Thromboembolism in the Setting of an Anatomical Thrombophilia
  • 2018 Session | Paper Session - Children's Oncology Group (COG)
  • 2018 Session | Paper Session - Hematology Science
  • 2018 Session | Can Late Effects be Prevented in Pediatric Oncology?
  • 2018 Session | Clash of the Titans: Debates on Best Management of Patients with Bleeding Disorders
  • 2018 Session | Providing Effective Feedback: The Currency of Conflict Resolution
  • 2018 Session | Recent Advances and New Approaches to Rare Hematological Malignancies
  • 2018 Session | Primary and Secondary Stroke Prevention in Sickle Cell Disease: The Debate
  • 2018 Session | Combating an Unmet Need: Psychosocial Health
  • 2018 Session | Renal Tumors Beyond Wilms
  • 2018 Session | Pediatric and Neonatal Transfusion Medicine
  • 2018 Session | Mobile Applications in Clinical Practice
  • 2018 Session | Presidential Symposium—Partnering with Patients and Families to Improve Research and Clinical Decision-making
  • 2018 Session | Review of Rare Pediatric Head and Neck Tumors for the General Oncologist
  • 2018 Session | Emerging Therapies in Hemophilia
  • 2018 Session | How Should You Treat That Bug? A Debate About Antimicrobial Management in Fever and Neutropenia
  • 2018 Session | Paper Session with Luminary Investigator - Leukemia
  • 2018 Session | Paper Session with Luminary Investigator - Hematology
  • 2018 Session | Frank A. Oski Memorial Lectureship Award Presentation
  • December 2018 eNews
  • 2019 Session | Splenectomy - The Great Debate
  • 2019 Session | DICER1: Updates on Biology and Clinical Management
  • 2019 Session | Burnout in Pediatric Hematology/Oncology: Moving from Discussion to Action
  • 2019 Session | Diagnostic and Management Conundrums Surrounding Women with Heavy Menstrual Bleeding and Underlying Bleeding Disorders
  • 2019 Session | All That Glitters is Not Gold – How We Differentiate Primary HLH from Fake News
  • Models for International Pediatric Oncology Outreach
  • 2019 Session | Navigating Genetic Testing in the Pediatric Hematology Setting
  • 2019 Session | Radiation Therapy for Pediatric Cancer Patients: Updates and New Modalities
  • 2019 Session | The Microbiome: What Is It and Why Do We Care?
  • 2019 Session | Brain Attack: Therapeutic Advances in Neonatal and Childhood Stroke
  • 2019 Session | Advances in Pediatric AML
  • 2019 Session | Improving Medication Adherence for Adolescents and Young Adults: Is Technology the Answer?
  • 2019 Session | Metabolism in Pediatric Hematology/Oncology - Presidential Symposium
  • 2019 Session | Too Much of a Good Thing – Myeloproliferation in Children
  • 2019 Session | Multiple Bony Lytic Lesions, but Not Langerhans Cell Histiocytosis (LCH) – Now What?
  • 2019 Session | Savior Siblings: Medical, Ethical, and Psychosocial Considerations in using Preimplantation Genetic Diagnosis (PGD) to Ensure a Matched Sibling Donor for Hematopoietic Stem Cell Transplantation (HSCT)
  • 2019 Session | George R. Buchanan Lectureship Award Presentation
  • 2019 Session | 2019 St. Baldrick’s Foundation Robert J. Arceci Innovation Award Announcement and Past Recipient Presentation
  • 2019 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship Announcement and Frank A. Oski Memorial Lectureship Award Presentation
  • 2019 Session | New Paradigms for Severe Aplastic Anemia: Genetic Screening, Eltrombopag, and Up Front Unrelated Donor BMT
  • 2019 Session | Not Too Young for That Cancer: Adolescent and Young Adult Carcinomas
  • 2019 Session | Transforming the Treatment of Chronic Pain
  • 2019 Session | Putting an End to End Organ Damage in Sickle Cell Disease
  • 2019 Session | Defining Pediatric MDS: A Morphologic or Molecular Diagnosis?
  • 2019 Session | The Power of One: Present Challenges in Treating Rare Diseases
  • 2019 Session | Hematological Manifestations of Immune Deficiencies and Dysregulatory Disorders: When should you look harder for underlying causes of Autoimmune Cytopenias?
  • 2019 Session | Oncofertility Programs: More Than Just Sperm Banking
  • 2019 Session | The (Financial) Cost of a "Cure"
  • 2019 Session | (2001) Potential Utility of MRD to Identify Relapse in pALL Patients Treated with Tisagenlecleucel
  • 2019 Session | (2002) Lentiglobin Gene Therapy in Transfusion-Dependent Β-Thalassemia Patients with Non-β0/β0 Genotypes
  • 2019 Session | (2003) Mechanisms of Resistance to the Type II JAK2 Inhibitor CHZ868 in B-Cell Acute Lymphoblastic Leukemia
  • 2019 Session | (2004) Discovering Noncoding Genetic Elements that Regulate Globin Synthesis
  • 2019 Session | (2005) Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis: Safety & Efficacy
  • 2019 Session | (2006) Modeling IKZF1 Lesions in B-cell Acute Lymphoblastic Leukemia Reveals Potential Therapeutic Targets
  • 2019 Session | (2007) Prognostic Determinants in Childhood T-cell Acute Lymphoblastic leukemia: Results of DFCI 05001
  • 2019 Session | (2008) Gap Junction Interference increases Apoptosis in ALL cells and augments effects of Antimetabolites
  • 2019 Session | (2009) Hydroxyurea Lowers Tricuspid Regurgitant Jet Velocity in Children with Sickle Cell Anemia
  • 2019 Session | (2010) Novel Next-Generation Sequence based Assay for Non-Invasive Prenatal Testing of Sickle Cell Disease
  • 2019 Session | (2011) Gabapentin for Pain in Sickle Cell Disease: Results of a Randomized Phase II Clinical Trial
  • 2019 Session | (2012) Quality of Life is the most important Indication for Second-Line ITP Treatment in Children
  • 2019 Session | (2013) BCL2-Inhibitor Response in Neuroblastoma: Biomarkers and Therapy Resistance
  • 2019 Session | (2014) The Clinical Application of Molecular Testing in Pediatric Solid Tumors: An Institutional Experience
  • 2019 Session | (2015) Enhancing Tumor Directed T Cells with an Interleukin-7 Signal Modulator
  • 2019 Session | (2016) Epigenome Screening Identifies Transcriptional Elongation as Therapeutic Vulnerability in DIPG
  • 2019 Session | (2017) Levofloxacin Prophylaxis
  • 2019 Session | (2018) Renal Tumors: Future Roadmap
  • 2019 Session | (2019) Soft Tissue Sarcoma
  • 2019 Session | (2020) Realizing Effectiveness across Continents with Hydroxyurea (REACH): A Prospective Multi-National Trial of Hydroxyurea for Sickle Cell Anemia in Sub-Saharan Africa
  • 2019 Session | (2021) Leucine for the Treatment of Transfusion Dependence in Patients with Diamond Blackfan Anemia
  • 2019 Session | (2022) A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds
  • 2019 Session | (2023) Peripherally Inserted Central Catheters (PICCs), the Leading Cause of Central Venous Catheter Associated Thrombosis in Children
  • 2019 Session | The Role of Survivorship Research in Advancing Childhood Cancer Care and Quality of Survival
  • 2019 Session | (2024) Septic Shock (SS) Incidence in National ALL & AML Cohorts using Administrative & Clinical Trial Data
  • 2019 Session | (2025) Nelarabine Abrogates Relapse Rates in CNS-3 T-ALL: A Report from Children’s Oncology Group AALL0434
  • 2019 Session | (2026) Current Cancer Survivorship Practices: A Report from the Children’s Oncology Group (COG)
  • 2019 Session | (2027) Intra-Arterial Chemotherapy for Retinoblastoma: A 7-year Single Institution Experience
  • 2019 Session | Advancing Discovery in Hematology: Bench to Bedside? No. Bedside to Bench to Bedside...
  • 2019 Session | (2028) The Shwachman Diamond Syndrome Registry: Hematologic Complications
  • 2019 Session | (2029) Characteristics and Outcomes of Unprovoked Venous Thromboembolism in the Pediatric Population
  • 2019 Session | (2030) Third Party VST are an effective Therapy for the Treatment of BK-Virus Reactivation after Transplant
  • 2019 Session | (2031) Inhibition of Nemo-Like Kinase improves Erythropoiesis in Models of Diamond Blackfan Anemia
  • CI SIG Webinar
  • October 2021 eNews
  • 2025 Conference App Download Instructions

Articles

2026 Conference

  •  Print 
  • Email
Details
Written by McKenney Leavell
Category: Conference
Published: 18 April 2025
Hits: 559

2026 ASPHO Conference

Save the Date! Learn and Network with the PHO Community at the Premier Subspecialty Conference

The leading conference for pediatric hematology/oncology subspecialists awaits you next spring at the 2026 ASPHO Conference! Don't miss the premier conference for subspecialty education, networking, and inspiration at the 2026 ASPHO Conference in Minneapolis, MN, April 29 - May 2, 2026.

Call Dates:

2026 Call for Workshops
May 7 - July 31, 2025

2026 Call for Abstracts
October 2 - December 18, 2025

2026 Call for Late-Breaking Abstracts
January 5 - January 29, 2026

Cancellation FAQ

  •  Print 
  • Email
Details
Written by Emma Stevens
Category: Conference
Published: 20 March 2020
Hits: 4619

Frequently Asked Questions

Will be updated as needed.

ASPHO is compiling helpful resources for pediatric hematologists/oncologists relevant to COVID-19. Learn more.

Why is the 2020 ASPHO Conference cancelled?

After closely monitoring updates and recommendations from the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and Texas health agencies, and considering the health and well-being of our members, speakers, partners and patients, the ASPHO Board of Trustees has made the difficult decision to cancel the 2020 ASPHO Conference.

Are all additional events associated with the 2020 ASPHO Conference cancelled as well?

All additional events including receptions, exhibit hall, pre-conference sessions, committee meetings, and Special Interest Group (SIG) meetings are also cancelled. If you were meeting with another organization onsite, including but not limited to PTCTC (formerly PBMTC) or AAP SOHO, please reach out to them directly with questions.

Will the conference be rescheduled or postponed?

No, the 2020 ASPHO Conference is being cancelled. The annual Business Meeting will be held by webinar during the dates of the canceled conference – the exact time and date will be determined and communicated in the coming weeks.

Will attendees and exhibitors receive a full refund?

Per ASPHO’s Cancellation Policy, registrants will receive full refunds of their conference registration fees within the next 60-90 days and we’ll let you know if we need any additional information. Please be patient as we process refunds for attendees, exhibitors, vendors and other partners.

Exhibitors and sponsors will have two options: receive a full refund or apply their fee towards the 2021 ASPHO Conference scheduled for April 21-24 in Portland, OR.

Will attendees and exhibitors be refunded for hotel and airline expenses?

Per ASPHO’s Cancellation Policy, no refunds can be made for lodging, airfare, or any other expenses related to attending the conference. We suggest you contact your hotel to cancel your reservation and your airline to request a refund. If they are unwilling to grant a full refund, they may be willing to reschedule you for another flight in the future.

  • Alaska Airlines
  • American Airlines
  • Delta Airlines
  • Southwest Airlines
  • United Airlines

Note: If you booked a hotel room at the Omni Fort Worth and Sheraton Fort Worth hotels and were part of the ASPHO room block, they have automatically canceled your room reservation. We encourage you to still call to be sure you aren't accidentally charged.

If I wanted to support ASPHO with a donation or transfer my registration fee to a donation, is that possible?

ASPHO is a 501(c)(3) organization and does accept charitable contributions. If you would like to donate your registration fee or a portion thereof, please email This email address is being protected from spambots. You need JavaScript enabled to view it. by March 31, 2020. You will be sent a donation acknowledgement letter for your records.

When and where is the next ASPHO Conference?

The 2021 ASPHO Conference will be held April 21-24 at the Oregon Convention Center in Portland, Oregon.

Will ASPHO present any sessions virtually?

The Conference Planning and Education Committees will be exploring opportunities to deliver some content originally meant to be presented at the 2020 Conference. More details will be shared in the coming weeks.

When will the 2021 Call for Workshops and Call for Papers and Posters be available?

The Conference Planning and Education Committees will be exploring many options for the 2021 ASPHO Conference, and more details will be shared in the coming weeks.

I was selected to present an abstract in paper or poster format. Is it possible to present my work in an alternative format?

All accepted abstracts will be published in Pediatric Blood and Cancer and are listed on the ASPHO website.

The Conference Planning and Education Committees will be exploring opportunities to deliver some content originally meant to be presented at the 2020 Conference. More details will be shared in the coming weeks.

I was scheduled to present a session, paper or poster at the 2020 ASPHO Conference. Does the cancellation of the meeting mean I can no longer list my presentation on my resume or CV?

In discussion with several leaders in the academic community, it is their opinion it is acceptable to include your presentation or poster on your CV and note the conference was cancelled. You are also advised to inquire with your own division/department leadership if you are up for promotion soon.

Sample listing: Presentation/poster title, indicate accepted (alternatively invited if asked to present), scheduled to be delivered on ___ (date) yet not delivered due to reason (conference cancellation/travel restriction reason)

Meetings Archive

  •  Print 
  • Email
Details
Written by Meghan McLaughlin
Category: Conference
Published: 11 May 2017
Hits: 26012

ASPHO Conference Archive

2024 Conference

2024 Conference
April 3-6, 2024
ASPHO Conference Abstract Issue, Pediatric Blood & Cancer

2023 Conference 

2023 Conference
May 10-13, 2023
ASPHO Conference Abstract Issue, Pediatric Blood & Cancer

2022 Conference 

2022 Conference
May 4-7, 2022
ASPHO Conference Abstract Issue, Pediatric Blood & Cancer

2021 Conference (Virtual)

2021 Conference
April 20-23, 2021
ASPHO Conference Abstract Issue, Pediatric Blood & Cancer

2018 Call for Workshops

  •  Print 
  • Email
Details
Written by Meghan McLaughlin
Category: Conference
Published: 22 May 2017
Hits: 3292

ASPHO18 Conf HL

Call for Workshops - Closed

2018 ASPHO Annual Meeting
May 2-5, 2018
Pittsburgh, PA

General Information Regarding Workshops

The American Society of Pediatric Hematology/Oncology will hold its 2018 Annual Meeting, May 2-5, 2018 in Pittsburgh, PA. The ASPHO Annual Meeting Committee invites the submission of proposals for workshops to be presented during the meeting in Pittsburgh.

The Annual Meeting Committee requests that proposals be interactive, problem-solving discussions, debates, cases, etc, and geared towards the educational needs of a specific audience. Topics can focus on particular diseases, clinical trial updates, disease registries, or professional development. Your proposal will be scored based on both content and planned audience engagement. Moderators should seek participants from a varied group of faculty (e.g., multiple institutions).

All workshops will have one person assigned from the Annual Meeting Committee to provide oversight to insure interactivity, review presentation slides two weeks prior to the meeting, verify that the presenters provide a balance between clinical and biology during the session, and verify that no more than two people from one institution will be represented.

**SPEAKER REIMBURSEMENT POLICY**
Each session is limited to a moderator and up to 3 additional speakers (3 members, 1 nonmember). Member speakers will receive $250 honorarium for their participation in the workshop. Nonmembers who are pediatric hematologist/oncologists will receive $250 honorarium for their participation in the workshop. Nonmembers who are NOT pediatric hematologist/oncologists will receive: $250 honorarium, one round trip coach airfare, one night at the meeting hotel, and meeting registration. Any requests differing from this policy will need to have written documentation supporting the need and must be approved by the Board of Trustees

Submissions will need to include a clearly articulated rationale for the session, which describes the need and intended outcome. As part of your description you will be asked to answer these questions:

  1. What is the gap or problem that exists and how will it be addressed?
  2. Why is there a gap or problem? What is causing it to occur?
  3. What will learners be able to do with this information?

You will also be asked to provide one source of data which speaks to the need for this topic (this can be needs assessment data, statistics regarding the topic, etc.).

Important Dates

Submission
The submittal system will remain open from May 30 to July 25, 2017. The system will close at 11:59 am Pacific Time on the deadline date and additional submissions will not be accepted.

Notification
Applicants will be notified in September of 2017 regarding selection of their workshop.

Faculty Disclosure Requirements
The American Society of Pediatric Hematology/Oncology requires full faculty disclosure and a speaker agreement from all faculty. Completed disclosure forms and speaker agreement must be received by August 8, 2017, to be reviewed and discussed for potential and real conflicts of interest by the Education Committee. Please note that the submission system will close on July 25, but the forms will remain accessible to faculty until August 8, 2017. Faculty members failing or refusing to complete the forms will be prohibited from participating in the meeting. The American Society of Pediatric Hematology/Oncology requires that all contributions to a CME activity are based on the best available evidence (refer to Policy on Content Validation).

All proposed speakers named on this proposal will receive an e-mail notice which instructs each of them, individually, to visit the proposal before the August 8, 2017 submission deadline to complete their disclosure form and speaker agreement. This notice will be sent to all speakers as soon as the submission forms are complete and the "Submit this Proposal now for review" button has been selected. Additionally, moderators should contact the speakers named on the proposal to notify them of their inclusion in the submission and to remind them to complete their disclosure information and speaker agreement before the August 8 deadline.

Proposals for Workshops
Workshops are scheduled to take place Wednesday, May 2 - Saturday, May 5, 2018. All faculty must be willing and able to present on these dates. Workshop sessions are 90 minutes in length.

For each submission, you will be asked for:

  • Presentation title
  • Presentation description (75 words for publication in the conference brochure)
  • Learning objectives (2-3 statements defining the expected outcomes)
  • Information source
  • Agree to work with a member of the Annual Meeting Committee for oversight of your workshop. You and your speakers will be expected to submit your presentation slides to this committee member two weeks prior to the meeting
  • Presentation outlines (a minimum of half the time should be interaction with cases, debates, etc.)
  • Provide details on how you plan to make your workshop interactive
  • Proposed Young Investigator to be involved in the planning and implementation of this workshop (including title, institution and contact information)
  • Moderator and presenter contact information (include: name, credentials, employer, address, phone, fax, email, and if different from above, presentation title)
  • If more than one speaker is from the same institution, please justify why you feel this is necessary

Submit Proposal

For questions regarding the ASPHO meeting or your proposal, please contact ASPHO Member Services by email at This email address is being protected from spambots. You need JavaScript enabled to view it.  or by phone at 847/375-4716.

 

Andrew's Test

  •  Print 
  • Email
Details
Written by Andrew Nieman
Category: Conference
Published: 14 October 2014
Hits: 307

ASPHO Test Page.

Here is some text.

 

Here is some more text. 

  1. ASPHO Annual Meeting

Subcategories

2017 Annual Meeting

2018 Conference

2019 Conference

2020 Conference

2021 Conference

2022 Conference

2023 Conference

2024 Conference

2025 Conference

Page 1 of 2

  • Start
  • Prev
  • 1
  • 2
  • Next
  • End
Advertising, Exhibits, & Support | Career Center | Calendar | Contact Us
Terms of Use & Privacy Policy » © The American Society of Pediatric Hematology/Oncology®